Literature DB >> 17230484

Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis.

Andrew H Evans, Helmut Butzkueven.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17230484     DOI： 10.1002/mds.21303

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  15 in total

1.  A case of compulsive behaviors observed in a restless legs syndrome patient treated with a dopamine agonist.

Authors:  Rachel E Salas; Richard P Allen; Christopher J Earley; Charlene E Gamaldo
Journal:  Sleep       Date:  2009-05       Impact factor: 5.849

2.  Quality measures for the care of adult patients with restless legs syndrome.

Authors:  Lynn Marie Trotti; Cathy A Goldstein; Christopher G Harrod; Brian B Koo; Denise Sharon; Rochelle Zak; Ronald D Chervin
Journal:  J Clin Sleep Med       Date:  2015-03-15       Impact factor: 4.062

Review 3.  The treatment of restless legs syndrome and periodic limb movement disorder in adults--an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline.

Authors:  R Nisha Aurora; David A Kristo; Sabin R Bista; James A Rowley; Rochelle S Zak; Kenneth R Casey; Carin I Lamm; Sharon L Tracy; Richard S Rosenberg
Journal:  Sleep       Date:  2012-08-01       Impact factor: 5.849

4.  Pathological gambling plus hypersexuality in restless legs syndrome: a new case.

Authors:  Giuseppe d'Orsi; Vincenzo Demaio; L M Specchio
Journal:  Neurol Sci       Date:  2011-05-13       Impact factor: 3.307

5.  Increased Risk for New-Onset Psychiatric Adverse Events in Patients With Newly Diagnosed Primary Restless Legs Syndrome Who Initiate Treatment With Dopamine Agonists: A Large-Scale Retrospective Claims Matched-Cohort Analysis.

Authors:  Cheryl Hankin; Daniel Lee; Diego Garcia-Borreguero; Zhaohui Wang
Journal:  J Clin Sleep Med       Date:  2019-09-15       Impact factor: 4.062

Review 6.  Sleep-related movement disorders.

Authors:  Giovanni Merlino; Gian Luigi Gigli
Journal:  Neurol Sci       Date:  2011-12-28       Impact factor: 3.307

Review 7.  Impulse control disorders in Parkinson's disease: recent advances.

Authors:  Valerie Voon; Arpan R Mehta; Mark Hallett
Journal:  Curr Opin Neurol       Date:  2011-08       Impact factor: 5.710

Review 8.  Behavioural adverse effects of dopaminergic treatments in Parkinson's disease: incidence, neurobiological basis, management and prevention.

Authors:  Angelo Antonini; Roberto Cilia
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

9.  Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study.

Authors:  T D L Steeves; J Miyasaki; M Zurowski; A E Lang; G Pellecchia; T Van Eimeren; P Rusjan; S Houle; A P Strafella
Journal:  Brain       Date:  2009-04-03       Impact factor: 13.501

Review 10.  A practical approach to the diagnosis and management of sleep disorders in patients with multiple sclerosis.

Authors:  Tiffany J Braley; Ronald D Chervin
Journal:  Ther Adv Neurol Disord       Date:  2015-11       Impact factor: 6.570
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.